Rifai, Mahmoud Al
Ballantyne, Christie M. http://orcid.org/0000-0002-6432-1730
Article History
First Online: 18 October 2021
Competing interests
: C.M.B. has received grant/research support (to his institution) from Abbott Diagnostics, Akcea, Amgen, Esperion, Ionis, Novartis, Regeneron and Roche Diagnostic, and has been a consultant for Abbott Diagnostics, Althera, Amarin, Amgen, Arrowhead, AstraZeneca, Corvidia, Denka Seiken, Esperion, Genentech, Gilead, Matinas BioPharma, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic and Sanofi-Synthelabo. M.A.R. declares no competing interests.